Financial Counselors Inc. Sells 475 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Financial Counselors Inc. lessened its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,402 shares of the company’s stock after selling 475 shares during the quarter. Financial Counselors Inc.’s holdings in GE HealthCare Technologies were worth $976,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. increased its stake in GE HealthCare Technologies by 12.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company’s stock worth $254,422,000 after purchasing an additional 290,019 shares during the period. Van ECK Associates Corp purchased a new position in GE HealthCare Technologies in the 3rd quarter worth about $208,513,000. FMR LLC increased its stake in GE HealthCare Technologies by 4.1% in the 3rd quarter. FMR LLC now owns 2,165,826 shares of the company’s stock worth $203,263,000 after buying an additional 84,411 shares during the period. Swiss National Bank lifted its holdings in GE HealthCare Technologies by 0.5% during the 3rd quarter. Swiss National Bank now owns 1,287,187 shares of the company’s stock valued at $120,802,000 after buying an additional 6,500 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its position in GE HealthCare Technologies by 18.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,245,961 shares of the company’s stock valued at $97,088,000 after buying an additional 189,956 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on GEHC shares. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective for the company. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their target price for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Finally, Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $94.36.

GE HealthCare Technologies Stock Up 0.3 %

Shares of GEHC opened at $83.22 on Friday. The company has a market capitalization of $38.02 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 2.97 and a beta of 1.24. GE HealthCare Technologies Inc. has a 52 week low of $66.39 and a 52 week high of $94.55. The stock’s 50-day moving average price is $87.92 and its 200-day moving average price is $83.61. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.99 EPS. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.